Piramal Enterprises has said it is looking to expand presence of its pharma vertical in global markets such as the US, Europe and Japan with plans to introduce more products.
North America and Europe account for over 70 per cent of the company’s revenue from pharmaceuticals business.
“Piramal will continue to add more generic hospital products both organically and inorganically to leverage its strong sales and distribution network, integrating acquired products and generating synergies,” Piramal Enterprises said in its annual report for 2016-17.
Piramal’s pharma vertical is divided into two — the global pharma business that sells pharma products and services globally and the India consumer products business that sells OTC products in India.
The company operates through its own field force in the US, the UK, Italy, and Germany and through more than 80 business partners in other countries. It has distribution presence in over 110 countries.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.